期刊文献+

淋巴管内皮透明质酸受体-1 mRNA在早期子宫内膜癌及癌旁组织中的表达及其意义

Expression of LYVE-1 mRNA in early stage endometrial carcinoma and its peritumoral stroma
全文增补中
导出
摘要 目的探讨淋巴管内皮透明质酸受体-1(LYVE-1)mRNA在早期子宫内膜癌组织及癌旁组织中的表达及其意义。方法采用反转录-聚合酶链反应(RT-PCR)方法对22例Ⅰ、Ⅱ期子宫内膜癌组织(T组)及其癌旁组织(PT组)、13例正常子宫内膜组织(NE组)中LYVE-1的表达进行检测。结果LYVE-1在三组均有表达,PT组表达最高(1.2440±0.1036),NE组和T组表达依次降低(分别为0.9889±0.1365,0.7812±0.1796),三组相对含量比较差异有统计学意义(P<0.01)。PT组Ⅰ期和Ⅱ期患者LYVE-1表达差异有统计学意义(P<0.05)。而PT组LYVE-1表达水平与子宫内膜癌临床病理分级、病理类型和肌层浸润程度无相关性(P>0.05)。结论LYVE-1在癌旁组织高表达,提示早期子宫内膜癌癌旁组织有新生淋巴管生成,从而可能进一步促进淋巴结转移。 Objective To study the expression and clinical significance of lymphatic vessel endothe- lial hyaluronan receptor LYVE-1 in early stage endometrial carcinoma and its peritumoral stroma.Methods Expression of LYVE-1 mRNA were assessed by semi-quantitative reverse transcription-polymerase chain re- action(RT-PCR)in 22 cases of early stage endometrial carcinoma(T group),its corresponding peritumoral stro- ma(PT group),and 13 cases of normal endometrium(NE group).Results LYVE-1 mRNA were detected in all 3 groups.The expression level of LYVE-1 in PT group was the highest(1.2440±0.1036)compared with the other 2 groups.LYVE-1 mRNA in NE group and T group were 0.9889±0.1365 and 0.7812±0.1796 respec- tively.There was a significant difference among the 3 gronps(P<0.01).In PT group,the LYVE-1 mRNA was higher in stageⅡthan in stageⅠ(P<0.05),while the expression of LYVE-1 mRNA were irrelevant to the surgico-pathological grade,pathological subtype and myometrial infiltration depth(P>0.05).Conclusion The high expression of LYVE-1 in peritumoral stroma indicates lymphangiogenesis,and then may promote lym- phatic metastasis.
出处 《肿瘤研究与临床》 CAS 2007年第3期159-161,共3页 Cancer Research and Clinic
关键词 子宫内膜肿瘤 淋巴管生成 基因 LYVE-1 Endometrial neoplasms Lymphangiogenesis Gene,LYVE-1
  • 相关文献

参考文献8

  • 1尚海霞,吴素慧.肿瘤淋巴管生成的研究进展[J].肿瘤研究与临床,2005,17(5):356-358. 被引量:1
  • 2Dadras SS,,Paul T,Bertoncini J,et al.Tumor lymphangiogenesis A novel prognostic indicator for cutaneous melanoma metastasis and survival. American Journal of Pathology . 2003
  • 3Karpanen T,Egeblad N,Karkkainen MJ,et al.Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Research . 2001
  • 4Stacker SA,Achen MG,Jussila L,et al.Lymphangiogenesis and cancer metastasis. Nature Reviews Cancer . 2002
  • 5He Y,Karpanen T,Alitalo K.Role of lymphangiogenic factors in tumor metastasis. Biochimica et Biophysica Acta . 2004
  • 6Williams C S,Leek R D,Robson A M,et al.Absence of lym-phangiogenesis and intratumoural lymph vessels in human metastat-ic breast cancer. Journal of Paleopathology . 2003
  • 7M andriota SJ,,Jussila L,Jc ltsch M,et al.Vascu larendothelial growth factor-Cm ed iated lymphangiogenesis pro-motes tumourm etastasis. EMBO Journal . 2001
  • 8Parr C,Jiang W G.Quantitative analysis of lymphangiogenic markers in human colorectal cancer. International Journal of Oncology . 2003

二级参考文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部